We launched the o2h kickstarter competition in 2022 to provide a chemistry boost to small molecule focused early stage biotech companies that had secured initial funding, have exciting drug targets and ability to scale. We have completed three series of this competition across the UK, Australia & Israel, and now have granted ten awards.

To extend the reach of this initiative to other therapeutic-focused startups, o2h discovery has now introduced the concept of 'Golden Partners.'

Venture Capital firms, Medical Institutions, Charities, and University Technology Transfer offices can become Golden Partners and nominate new investments made into biotech companies for a fast-track 'kickstarter award.' This award provides the recipient company with a chemistry boost to help achieve their project milestones. Becoming a Golden Partner is straightforward and one can apply from our website.